Cargando…

Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors

Growth Hormone-secreting adenomas exhibits variable biological behavior and heterogeneous natural history, ranging from small adenomas and mild disease, to invasive and aggressive neoplasms with more severe clinical picture. Patients not cured or controlled after neurosurgical and first-generation s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bianchi, Antonio, Chiloiro, Sabrina, Giampietro, Antonella, Gaudino, Simona, Calandrelli, Rosalinda, Mazzarella, Ciro, Caldarella, Carmelo, Rigante, Mario, Gessi, Marco, Lauretti, Liverana, De Marinis, Laura, Olivi, Alessandro, Pontecorvi, Alfredo, Doglietto, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189777/ https://www.ncbi.nlm.nih.gov/pubmed/37206441 http://dx.doi.org/10.3389/fendo.2023.1123267

Ejemplares similares

THU055 The Acro-TIME Score: A New Clinical, Pathological And Immune Integrative Approach To Early Identify Acromegaly Patients Resistant To Treatment With First Generation Somatostatin Ligands
por: Chiloiro, Sabrina, et al.
Publicado: (2023)

Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors
por: Mattogno, Pier Paolo, et al.
Publicado: (2021)

THU050 The Role Of The GH Receptor Polymorphism As Prognostic Factor Of Vertebral Fractures In Acromegaly Patients Resistant To First Generation SSAs And Treated With GH Receptor Antagonist Or Second Generation Somatostatin Ligand
por: Costanza, Flavia, et al.
Publicado: (2023)

SUN-LB076 Potential Role of Gallium-68-Peptides and Fluorine-18-FDG PET/CT and Ki67 in Patients with Post-Surgical Residual Pituitary Adenoma
por: Chiloiro, Sabrina, et al.
Publicado: (2019)

Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study
por: Bima, Chiara, et al.
Publicado: (2021)

Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours
por: Iacovazzo, Donato, et al.
Publicado: (2019)

Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways
por: Serioli, Simona, et al.
Publicado: (2023)

Gastrointestinal carcinoma first presenting as pituitary mass: recognition of a rare case and multidisciplinary approach for the management of pituitary metastases
por: Costanza, Flavia, et al.
Publicado: (2023)

Treatment of Clival Chordomas: A 20-Year Experience and Systematic Literature Review
por: Noya, Carolina, et al.
Publicado: (2023)

Reliability of intraoperative visual evoked potentials (iVEPs) in monitoring visual function during endoscopic transsphenoidal surgery
por: Mattogno, Pier Paolo, et al.
Publicado: (2023)

Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review
por: Menotti, Sara, et al.
Publicado: (2023)

Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: a pilot study
por: Chiloiro, Sabrina, et al.
Publicado: (2021)

Training models and simulators for endoscopic transsphenoidal surgery: a systematic review
por: Santona, Giacomo, et al.
Publicado: (2023)

Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma
por: Chiesa, Silvia, et al.
Publicado: (2022)

Treatment of giant congenital cysts of the midline in adults: Report of two cases and review of the literature
por: Lauretti, Liverana, et al.
Publicado: (2015)

Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin?
por: Chiloiro, Sabrina, et al.
Publicado: (2023)

Quantitative Anatomical Studies in Neurosurgery: A Systematic and Critical Review of Research Methods
por: Agosti, Edoardo, et al.
Publicado: (2023)

Reassessing the Role of Brain Tumor Biopsy in the Era of Advanced Surgical, Molecular, and Imaging Techniques—A Single-Center Experience with Long-Term Follow-Up
por: Di Bonaventura, Rina, et al.
Publicado: (2021)

THU093 Pituitary Enlargement And Hypopituitarism In Patients Treated With Immune Checkpoint Inhibitors: Two Sides Of The Same Coin?
por: Menotti, Sara, et al.
Publicado: (2023)

Dissecting Stemness in Aggressive Intracranial Meningiomas: Prognostic Role of SOX2 Expression
por: Di Bonaventura, Rina, et al.
Publicado: (2022)

Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes
por: Bianchi, Antonio, et al.
Publicado: (2013)

Colon Cancer Presenting as Pituitary Mass and Hypopituitarism: Recognition and Multidisciplinary Approach of a Rare Case
por: Costanza, Flavia, et al.
Publicado: (2023)

Ultra-Early Treatment of Neurosurgical Emergencies with Endoscopic Endonasal Approach: Experience from Three Italian Referral Centers
por: Mattogno, Pier Paolo, et al.
Publicado: (2023)

MON-311 Glucose Metabolism in Acromegaly Patients Resistant to First Generation Somatostatin Receptor Ligands Treated with Pegvisomant And/Or Pasireotide Lar
por: Chiloiro, Sabrina, et al.
Publicado: (2020)

The Neuro-Immune-Endocrine Connection
por: Stitt, John T.
Publicado: (1987)

Multidimensional assessment of cervical spondylotic myelopathy patients. Usefulness of a comprehensive score system
por: Pilato, Fabio, et al.
Publicado: (2020)

Neuro-Oncology Multidisciplinary Tumor Board: The Point of View of the Neuroradiologist
por: Gaudino, Simona, et al.
Publicado: (2022)

Atypical Teratoid Rhabdoid Tumor: Proposal of a Diagnostic Pathway Based on Clinical Features and Neuroimaging Findings
por: Calandrelli, Rosalinda, et al.
Publicado: (2023)

Transnasal endoscopic skull base surgery during COVID-19 pandemic: algorithm of management in an Italian reference COVID center
por: Mattogno, P. P., et al.
Publicado: (2020)

SUN-LB075 Effects of Pegvisomant and Pasireotide LAR on Incidence of Vertebral Fractures in Patients with Acromegaly Resistant to Treatment with First-Line Somatostatin Analogs
por: Chiloiro, Sabrina, et al.
Publicado: (2019)

Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience
por: Chiloiro, Sabrina, et al.
Publicado: (2022)

Paths of Evolution of Progressive Anaplastic Meningiomas: A Clinical and Molecular Pathology Study
por: Di Bonaventura, Rina, et al.
Publicado: (2023)

Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant
por: Chiloiro, Sabrina, et al.
Publicado: (2021)

Neuro-endocrine regulation of blood pressure
por: Chopra, Sandeep, et al.
Publicado: (2011)

Neuromodulation for Brain Tumors: Myth or Reality? A Narrative Review
por: D’Alessandris, Quintino Giorgio, et al.
Publicado: (2023)

Preliminary experience with 4K ultra-high definition endoscope: analysis of pros and cons in skull base surgery
por: Rigante, M., et al.
Publicado: (2017)

A Neuro-Vasculo-Endocrine Approach to Menopause
por: Kalra, Sanjay
Publicado: (2022)

Nerve Torsion as a Pattern of Parsonage–Turner Syndrome: Literature Review and Two Representative Cases
por: Glorioso, Davide, et al.
Publicado: (2023)

The Pituitary: Its Relation to the Endocrine System
por: Oastler, Eric G.
Publicado: (1937)

Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly
por: Chiloiro, Sabrina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gsuup9q6irn02d68uae2am7gjv